Raptiva (or efalizumab), a psoriasis drug, may cause a serious brain infection and even result in death. The Food and Drug Administration on Feb. 19 issued an advisory citing three confirmed cases — and a possible fourth case — of persons being diagnosed with progressive multifocal leukoencephalopathy (PML) after they were treated with Raptiva. The…
Continue reading →
Continue reading
For only the second time in VTLA’s 50-year history, a Life-time Achievement Award will be presented. Bob Hall was the President of the Virginia Trial Lawyers Association when I came to work for him in Fairfax after graduation from the University of Miami School of Law. He was my mentor, and we travelled all over…
Continue reading →
Continue reading
At the Virginia Trial Lawyers annual convention, Doug Landau had a chance to “run into” his friends and network so as to exchange ideas with other experienced injury and disability lawyers. One such lawyer is my good friend Chris Meyers of the Richmond law firm of Allen, Allen, Allen & Allen. The Landaus and Allens…
Continue reading →
Continue reading
In yesterday’s post I discussed the drug Reglan, what it is used for, why it may be dangerous and what kinds of claims are brought when a drug causes harm to innocent users. The negative side effect from this drug include a condition called “Tardive Dyskinesia.” “Tardive” means “late” or “tardy” and “Dyskinesia” (or “dyscinesia”)…
Continue reading →
Continue reading
Over 25 years ago, after graduate studies in Applied Anatomy & Physiology, I worked at the Association of Trial Lawyers of America headquarters in Georgetown. At the Drug Product Liability Exchange, we researched cases involving defective and dangerous drugs and assisted lawyers from around the world with cases on behalf of injured drug users. That…
Continue reading →
Continue reading